Abstract
We analysed the number of pulmonary embolism (PE) in young females aged 10–39 years in the period from 2005 to 2014 in Germany to see any trends that possibly may reflect some influences of newer oral contraceptives. Detailed lists of all hospitalized cases with the principal diagnosis PE coded as I26 in the years 2005–2014 were provided by the Federal Statistical Office. In males, the absolute number of all hospitalized cases with the principal diagnosis PE increased from 16,066 in 2005 to 25,364 in 2014 (rate +57.8%) and in females from 21,548 to 29,433 (rate +36.5%). The annual differences in PE between males and females decreased from 5482 to 4069 (−26%) in this period. In the age group of 10–39 years the absolute number of all hospitalized male cases increased from 1023 in 2005 to 1276 in 2014 (+24.7%) and in females from 1341 to 1949 (rate +45.3%). Thus in contrast to the overall trend the annual difference in PE rose gradually by 112% (from 318 to 673) from 2005 to 2014. Our ecologic nationwide analysis of hospitalization rates for PE shows that the annual differences between males and females cases hospitalized with the principal diagnosis PE in general decreased, but increased in the age group of 10–39 years in the last decade.
Similar content being viewed by others
References
Moysidis T, Kröger K, Moerchel C, Santosa F, Gröchenig E (2010) Pulmonary embolism in young males and females in Germany: data from the Federal Statistical Office. Blood Coagul Fibrinolysis 21:511–515
Santosa F, Moysidis T, Moerchel C, Kröger K, Bufe A (2014) Pulmonary embolism in young people. Trends in Germany from 2005 to 2011. Hämostaseologie 34:88–92
Wiener RS, Schwartz LM, Woloshin S (2013) When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ 347:f3368
Tsai J, Grosse SD, Grant AM, Hooper WC, Atrash HK (2012) Trends in in-hospital deaths among hospitalizations with pulmonary embolism. Arch Intern Med 172:960–961
Wiener RS, Schwartz LM, Woloshin S (2011) Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 171:831–837
Syed FF, Beeching NJ (2005) Lower-limb deep-vein thrombosis in a general hospital: risk factors, outcomes and the contribution of intravenous drug use. QJM 98:139–145
Moores L, Bilello KL, Murin S (2004) Sex and gender issues and venous thromboembolism. Clin Chest Med 25:281–297
Heit JA (2015) Epidemiology of venous thromboembolism. Nat Rev Cardiol 12:464–474
Eichinger S, Evers JL, Glasier A, La Vecchia C, Martinelli I, Skouby S, Somigliana E, Baird DT, Benagiano G, Crosignani PG, Gianaroli L, Negri E, Volpe A, Glasier A, Crosignani PG (2013) ESHRE Capri Workshop Group. Venous thromboembolism in women: a specific reproductive health risk. Hum Reprod Update 19:471–482
Dinger J, Assmann A, Möhner S, Minh TD (2010) Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J Fam Plann Reprod Health Care 36:123–129
Sehovic N, Smith KP (2010) Risk of venous thromboembolism with drospirenone in combined oral contraceptive products. Ann Pharmacother 44:898–903
Jick SS, Hernandez RK (2011) Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ 342:d2151.
Parkin L, Sharples K, Hernandez RK, Jick SS (2011) Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ 342:d2139
Bird ST, Delaney JA, Etminan M, Brophy JM, Hartzema AG (2013) Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol? J Thromb Haemost 11:1059–1068
Lidegaard Ø, Milsom I, Geirsson RT, Skjeldestad FE (2012) Hormonal contraception and venous thromboembolism. Acta Obstet Gynecol Scand 9:769–778
Acknowledgements
We thank Referat VIII A 1 from the Federal Statistical Office for extracting and providing the data from the DRG-Statistik.
Funding
No fundings received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
F. Santosa, Ch. Moerchel, Ch. Berg declares that they have no conflict of interest. K. Kröger has received a speaker honorarium from Bayer, Sanofi, Bristol Myers Squibb.
Rights and permissions
About this article
Cite this article
Santosa, F., Moerchel, C., Berg, C. et al. Disproportional increase of pulmonary embolism in young females in Germany: trends from 2005 to 2014. J Thromb Thrombolysis 43, 417–422 (2017). https://doi.org/10.1007/s11239-017-1486-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-017-1486-0